The new offering is slated to roll out in early 2026 and provide three levels of service through a subscription model.
Researchers report favorable safety and efficacy for a combination device after implantation and at 6 months follow-up among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback